Your browser doesn't support javascript.
loading
Macrophage-mediated myelin recycling fuels brain cancer malignancy.
Kloosterman, Daan J; Erbani, Johanna; Boon, Menno; Farber, Martina; Handgraaf, Shanna M; Ando-Kuri, Masami; Sánchez-López, Elena; Fontein, Bauke; Mertz, Marjolijn; Nieuwland, Marja; Liu, Ning Qing; Forn-Cuni, Gabriel; van der Wel, Nicole N; Grootemaat, Anita E; Reinalda, Luuk; van Kasteren, Sander I; de Wit, Elzo; Ruffell, Brian; Snaar-Jagalska, Ewa; Petrecca, Kevin; Brandsma, Dieta; Kros, Alexander; Giera, Martin; Akkari, Leila.
Afiliação
  • Kloosterman DJ; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Erbani J; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Boon M; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Farber M; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Handgraaf SM; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Ando-Kuri M; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Sánchez-López E; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
  • Fontein B; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Mertz M; Bioimaging Facility, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Nieuwland M; Genomics Core Facility, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Liu NQ; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Forn-Cuni G; Institute of Biology Leiden, Leiden University, Leiden, the Netherlands.
  • van der Wel NN; Electron Microscopy Centre Amsterdam, Medical Biology, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
  • Grootemaat AE; Electron Microscopy Centre Amsterdam, Medical Biology, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
  • Reinalda L; The Institute of Chemical Immunology, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
  • van Kasteren SI; The Institute of Chemical Immunology, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
  • de Wit E; Division of Gene Regulation, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Ruffell B; Department of Immunology, Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Snaar-Jagalska E; Institute of Biology Leiden, Leiden University, Leiden, the Netherlands.
  • Petrecca K; Montreal Neurological Institute-Hospital, McGill University Health Centre and Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC, Canada.
  • Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066CX Amsterdam, the Netherlands.
  • Kros A; Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
  • Giera M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
  • Akkari L; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands. Electronic address: l.akkari@nki.nl.
Cell ; 2024 Aug 07.
Article em En | MEDLINE | ID: mdl-39137777
ABSTRACT
Tumors growing in metabolically challenged environments, such as glioblastoma in the brain, are particularly reliant on crosstalk with their tumor microenvironment (TME) to satisfy their high energetic needs. To study the intricacies of this metabolic interplay, we interrogated the heterogeneity of the glioblastoma TME using single-cell and multi-omics analyses and identified metabolically rewired tumor-associated macrophage (TAM) subpopulations with pro-tumorigenic properties. These TAM subsets, termed lipid-laden macrophages (LLMs) to reflect their cholesterol accumulation, are epigenetically rewired, display immunosuppressive features, and are enriched in the aggressive mesenchymal glioblastoma subtype. Engulfment of cholesterol-rich myelin debris endows subsets of TAMs to acquire an LLM phenotype. Subsequently, LLMs directly transfer myelin-derived lipids to cancer cells in an LXR/Abca1-dependent manner, thereby fueling the heightened metabolic demands of mesenchymal glioblastoma. Our work provides an in-depth understanding of the immune-metabolic interplay during glioblastoma progression, thereby laying a framework to unveil targetable metabolic vulnerabilities in glioblastoma.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article